Reuters logo
BRIEF-Ganaxolone Phase 1 data supports progressing to Phase 2
2016年10月19日 / 中午11点47分 / 1 年前

BRIEF-Ganaxolone Phase 1 data supports progressing to Phase 2

Oct 19 (Reuters) - Marinus Pharmaceuticals Inc :

* Press release - Ganaxolone Phase 1 data supports progressing to Phase 2 in patients with status epilepticus

* Is making preparations to commence its Phase 2 clinical study in patients with SE in 2017.

* Marinus pharmaceuticals -Phase 1 dose-escalation study, Ganaxolone intravenous achieved dose levels targeted for efficacy in patients with status epilepticus Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below